Status:
UNKNOWN
The Efficacy of 1,064-nm Picosecond Laser With Microlens Array for the Treatment of Abdominal Striae Distensae
Lead Sponsor:
Mahidol University
Conditions:
Striae Alba
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the efficacy and safety of a fractional 1,064 nm picosecond laser for the treatment of striae alba.
Detailed Description
Striae distensae are atrophic dermal scars that can cause psychosocial distress on affected patients. Despite numerous available therapeutic modalities, no gold standard therapy has been established. ...
Eligibility Criteria
Inclusion
- Striae alba on abdomen for more than 3 months
- Fitzpatrick skin type III-V
Exclusion
- Pregnancy and breastfeeding
- Previous topical treatment, filler injection, chemical peel or laser treatment within 6 months before starting the study
- History of using Isotretinoin
- Photosensitive dermatoses, Infection, eczema
- Past history or family history of malignancy
- History of herpes infection
- History of hypertrophic scar or keloid, connective tissue disease
- History of collagen or elastin disease
- History of smoking
- Significant fluctuations in weight in the past 6 months
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04456257
Start Date
May 1 2020
End Date
December 30 2020
Last Update
July 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Siriraj hospital, Mahidol University
Bangkok Noi, Bangkok, Thailand, 10700